MIBio 2022 Programme

08:00 Registration opens

09:00 Opening remarks

09:15 Pharmaceutical Development of Biologics, Past Present and Future
Paul Varley | VP CMC Development, Alchemab Therapeutics Ltd.

09:45 Challenges of Low Dosing and Stability
Jordan Bye | Senior Scientist, Immunocore

10:15 Morning Coffee, Exhibition and Posters

11:00 Building a New Biology: Design and Construction of Synthetic Cells
Yuval Elani – Asst. Professor & UKRI Future Leaders Fellow, Imperial College

11:30 Process Development for First in Human biopharmaceuticals: the role of change control in manufacturing
Luca Badiali | Associate Director, Kymab Ltd, a Sanofi Company

12:00 Lunch Break, Exhibition and Posters

13:15 Introduction to the afternoon session

13:30 Lipid nanoparticles to accelerate development and patient access to cell therapies
Sara Pereira | Senior Scientist, AstraZeneca

14:00 Discussion Panel

15:00 Exhibitors highlights

15:30 Coffee break, Exhibition and Posters

16:00 Materials and production considerations for LNPs
Söhnke Voss | Business Development Manager, EMEA, Avanti Polar Lipids

16:30 Cell and Gene Therapy Product Development and Associated Challenges
Farnaz Esmaeili | Project Manager, Regulatory Affairs, Cell and Genetherapy, GSK

17:00 Concluding remarks

17:10 Conference ends